Mast cell leukemia with prolonged survival on PKC412/midostaurin.

Xu, Xiangdong; Kreisel, Friederike H; Frater, John L; Hassan, Anjum

Xu, Xiangdong; Kreisel, Friederike H; Frater, John L; Hassan, Anjum.

Afiliação

Xu X; Department of Pathology, School of Medicine, University of California, San Diego; VA San Diego Healthcare System San Diego CA, USA ; Department of Pathology and Immunology, School of Medicine, Washington University St. Louis MO, USA.
Kreisel FH; Department of Pathology and Immunology, School of Medicine, Washington University St. Louis MO, USA.
Frater JL; Department of Pathology and Immunology, School of Medicine, Washington University St. Louis MO, USA.
Hassan A; Department of Pathology and Immunology, School of Medicine, Washington University St. Louis MO, USA.

Int J Clin Exp Pathol ; 7(6): 3439-43, 2014.

Article em En | MEDLINE | ID: mdl-25031773

Assuntos

Antineoplásicos/uso terapêutico; Leucemia de Mastócitos/tratamento farmacológico; Leucemia de Mastócitos/patologia; Estaurosporina/análogos & derivados; Idoso; Ensaios Clínicos Fase II como Assunto; Feminino; Humanos; Estaurosporina/uso terapêutico

Palavras-chave

D816V; Mast cell leukemia; Midostaurin; PKC412; aleukemic variant; c-kit; prolonged survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia de Mastócitos / Estaurosporina / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google